Gastrointestinal eosinophils

Immunological Reviews

Volumn 179, Issue , 2001, Pages 139-155

  Rothenberg, Marc E ^a   Mishra, Anil ^a   Brandt, Eric B ^a   Hogan, Simon P ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; INTEGRIN; INTERLEUKIN 5;

ALLERGENICITY; ANTIGENICITY; DIGESTIVE SYSTEM INFLAMMATION; EOSINOPHIL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INTESTINE FLORA; LAMINA PROPRIA; PEYER PATCH; PRIORITY JOURNAL; REVIEW; TH2 CELL;

ADMINISTRATION, ORAL; ALLERGENS; ANIMALS; CHEMOKINES; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DIGESTIVE SYSTEM; EOSINOPHILIA; EOSINOPHILS; ESOPHAGUS; FOOD HYPERSENSITIVITY; GASTROINTESTINAL DISEASES; HELMINTHIASIS; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; INTEGRINS; INTERLEUKIN-5; INTESTINAL DISEASES, PARASITIC; LYMPHOID TISSUE; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; PEYER'S PATCHES; T-LYMPHOCYTE SUBSETS;

EID: 0035105357     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.790114.x     Document Type: Review

References (131)

1. The eosinophilic leukocyte: Structure and function
2. The immunobiology of eosinophils
3. Eosinophilia
4. CD40 expression by human peripheral blood eosinophils
5. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma). Inhibition by immunoglobulin A complexes
6. Mature human eosinophils have the capacity to express HLA-DR
7. Intracellular localization of interleukin-6 in eosinophils from atopic asthmatics and effects of interferon gamma
8. The eosinophil: A cytokine-producing cell?
9. Lymph node trafficking and antigen presentation by endobronchial eosinophils
10. The role of the eosinophil in gastrointestinal diseases
11. The role of eosinophils in the pathogenesis of asthma
12. Mechanisms of eosinophil-associated inflammation
13. Allergic gastroenteropathy in children
14. Interactions between food antigens and the immune system in the pathogenesis of gastrointestinal diseases
15. Milk-sensitive and eosinophilic gastroenteropathy: Similar clinical features with contrasting mechanisms and clinical course
16. Activated eosinophils in familial eosinophilic gastroenteritis
17. Eosinophilic gastroenteritis: Ultrastructural evidence for a selective release of eosinophil major basic protein
18. Neonatal eosinophilic colitis
19. Colitis caused by food allergy in infants
20. Allergic colitis in infants
21. The eosinophil in inflammatory bowel disease
22. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study
23. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: Cytotoxic potential in Crohn's disease
24. Intraepithelial eosinophils: A new diagnostic criterion for reflux esophagitis
25. Primary eosinophilic esophagitis in children: Successful treatment with oral corticosteroids
26. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis
27. Food allergy. Part 1: Immunopathogenesis and clinical disorders
28. Serum IgE in eosinophilic gastroenteritis
29. Eosinophilic gastroenteritis: A complex disease entity
30. Food allergy manifested by eosinophilia, elevated immunoglobulin E level, and protein-losing enteropathy: The syndrome of allergic gastroenteropathy
31. Gastroesophageal reflux and cow's milk allergy in infants: A prospective study
32. Food allergy
33. Eosinophilic gastroenteritis: A clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues
34. Eosinophilic gastroenteritis: Immunohistochemical evidence for IgE mast cell-mediated allergy
35. Eosinophilic gastroenteritis
36. Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: The Churg-Strauss syndrome
37. Cationic proteins of human eosinophils and their role in the inflammatory reaction
38. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium
39. Cytotoxic properties of the eosinophil major basic protein
40. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome
41. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis
42. Eosinophilic gastroenteritis
43. Quantitative analysis of small intestinal mucosa in cow's milk-sensitive enteropathy
44. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy
45. Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula
46. Eosinophil infiltration and degranulation in normal human tissue
47. Eotaxin is required for the baseline level of tissue eosinophils
48. The identification and cloning of a murine major basic protein gene expressed in eosinophils
49. Fundamental signals regulate eosinophil homing to the gastrointestinal tract
50. Growth and development of "antigen-free" grafts of foetal mouse intestine
51. The effect of antigen deprivation on thymus-dependent and thymus-independent lymphocytes in the small intestine of the mouse
52. Association of mastopoiesis with haemopoietic tissues in the neonatal rat
53. Purification of an atypical mast cell protease and its levels in developing rats
54. Models of intestinal hypersensitivity
55. Eosinophil function in health and disease
56. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo
57. The role of adhesion molecules in human eosinophil and basophil recruitment
58. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells
59. Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues
60. Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation
61. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes
62. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3
63. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils
64. Murine eotaxin-2: A constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression
65. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung
66. Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression
67. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
68. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
69. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts
70. Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells
71. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3
72. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity
73. Hemopoietins for eosinophils. Glycoprotein hormones that regulate the development of inflammation in eosinophilia-associated disease
74. Adhesion to fibronectin prolongs eosinophil survival
75. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
76. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
77. Allergen-specific IgE and IL-5 are essential for the development of airway hyper-responsiveness
78. RAG-1-deficient mice have no mature B and T lymphocytes
79. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
80. Eosinophilia in transgenic mice expressing interleukin 5
81. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
82. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice
83. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
84. Peyer's patch eosinophils: Identification, characterization, and regulation by mucosal allergen exposure, interleukin-5, and eotaxin
85. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE
86. Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice
87. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy
88. Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo
89. Sorting out the cytokines of asthma
90. Immunologic basis of antigen-induced airway hyperresponsiveness
91. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein V. Hierarchy of suppression by myelin basic protein from different species
92. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen
93. The role of digestive enzymes in orally induced immune tolerance
94. Antigen trafficking in the intestine
95. Oral tolerance: Mechanisms and applications. Introduction
96. Microencapsulation. The future of oral immunotherapy?
97. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles
98. The chemokine eotaxin is a central mediator of experimental eosinophilic gastrointestinal allergy
99. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxin of eosinophils to the site of inflammation
100. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics
101. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
102. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea
103. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
104. + T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice
105. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow
106. An etiological role for aeroallergens and eosinophils in experimental esophagitis
107. Immunopathology of schistosomiasis in athymic mice
108. Trichinella spiralis infection in congenitally athymic (nude) mice. Parasitological, serological and haematological studies with observations on intestinal pathology
109. Interleukin-5, eosinophils, and disease
110. Immunological modulation and evasion by helminth parasites in human populations
111. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice
112. The role of eosinophils in parasitic helminth infections: Insights from genetically modified mice
113. The eosinophil and its role in immunity to helminth infection
114. Cell-mediated damage to helminths
115. The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice
116. Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection
117. β7 integrin-deficient mice: Delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminthic infection
118. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1
119. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein
120. Molecular cloning of the human eosinophil-derived neurotoxin: A member of the ribonuclease gene family
121. Rapid evolution of a unique family of primate ribonuclease genes
122. Mechanism of membrane damage mediated by human eosinophil cationic protein
123. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor
124. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases
125. Cytokine generation by eosinophils
126. Innervation of mucosal immune cells in the gastrointestinal tract
127. Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils
128. The role of eosinophils in the pathobiology of Hodgkin's disease
129. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line
130. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes
131. Postnatal mammary gland development requires macrophages and eosinophils